| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2005;80:1706-1711
© 2005 The Society of Thoracic Surgeons
a New York University Medical Center, New York, New York
b Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
c University of Nebraska Medical Center, Omaha, Nebraska
d St. Joseph's Medical Center, Towson, Maryland
e St. Luke's Medical Center, Milwaukee, Wisconsin
f St. Joseph's Hospital and Medical Center, Phoenix, Arizona
g Nebraska Heart Institute, Lincoln, Nebraska
Accepted for publication April 25, 2005.
* Address correspondence to Dr Grossi, NYU Medical Center, Suite 9-V, 530 First Ave, New York, NY 10028 (Email: grossi{at}cv.med.nyu.edu).
BACKGROUND: Functional ischemic mitral regurgitation (MR) frequently arises after myocardial infarction; it is characterized by annular enlargement or lateral displacement of the subvalvular apparatus. Coapsys is a ventricular–annular remodeling device designed to treat functional ischemic MR; it does not require cardiopulmonary bypass. Initial intraoperative results of the RESTOR-MV randomized clinical trial are presented.
METHODS: Patients referred for coronary artery bypass grafting with preoperative MR grade of 2 or greater were studied, excluding those with structural valve abnormalities. The Coapsys device, which consists of two epicardial pads connected by a flexible cord, was surgically implanted in 19 patients. Under epicardial echocardiographic guidance, the cord was passed through the left ventricle and tightened externally to improve leaflet coaptation and stabilize the ventricular wall; tightening was conducted with color flow Doppler imaging.
RESULTS: Patients were 64.5 ± 9.2 years old with an ejection fraction of 0.383 ± 0.089 and received 2.7 ± 1.1 grafts. Intraoperative MR grade was 2.7 ± 0.8 after induction and was reduced to 0.4 ± 0.7 after implantation (p < 0.0001). Mean epicardial dimension was reduced from 8.5 ± 1.2 to 6.4 ± 0.9 cm (p < 0.0001). Intraoperative MR was reduced in 95% (18 of 19) of patients, and 84% (16 of 19) had MR grade 1 or less after implantation. All implants were performed without cardiopulmonary bypass or conversion to standard annuloplasty. No hemodynamic compromise or structural damage to the mitral apparatus was noted. Significant acute remodeling was noted in the left ventricular dimensions.
CONCLUSIONS: In patients without structural valve disease, the Coapsys device acutely reduces functional MR. Further randomized evaluation will assess long-term stability and compare it with standard annuloplasty techniques.
This article has been cited by other articles:
|
|
 |
|
  J.-B. Masson and J. G. Webb Percutaneous Treatment of Mitral Regurgitation Circ Cardiovasc Intervent, April 1, 2009; 2(2): 140 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Masuyama, A. Marui, T. Shimamoto, M. Nonaka, M. Tsukiji, N. Watanabe, T. Ikeda, K. Yoshida, and M. Komeda Chordal translocation for ischemic mitral regurgitation may ameliorate tethering of the posterior and anterior mitral leaflets. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Akiyama, Z. B. Popovic, K. Kamohara, F. Cingoz, M. Daimon, C. Ootaki, Y. Ootaki, M. Martin, J. Liu, M. W. Kopcak Jr, et al. Acute Reduction of Functional Mitral Regurgitation in Canine Model Using an Epicardial Device Ann. Thorac. Surg., May 1, 2008; 85(5): 1771 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, April 1, 2008; 117(13): 1750 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text]
|
|
|
|
|
|
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text]
|
|
|
|
|
|
T. Feldman and M. B. Leon Prospects for Percutaneous Valve Therapies Circulation, December 11, 2007; 116(24): 2866 - 2877. [Full Text] [PDF]
|
|
|
|
|
|
B.-C. Chang, Y.-N. Youn, J.-W. Ha, S.-H. Lim, Y.-S. Hong, and N. Chung Long-term clinical results of mitral valvuloplasty using flexible and rigid rings: A prospective and randomized study J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 995 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Nguyen, A. Cheng, F. A. Tibayan, D. Liang, G. T. Daughters, N. B. Ingels Jr., and D. C. Miller Septal-lateral annnular cinching perturbs basal left ventricular transmural strains Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.A. Grossi, Y.J. Woo, C.F. Schwartz, D.M. Gangahar, V.A. Subramanian, N. Patel, J. Wudel, P.L. DiGiorgi, A. Singh, and R.D. Davis Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: Impact on the left ventricle J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1095 - 1098. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
